5-Year overall survival | 5-Year disease-free survival | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Hemoglobin (non-anemic vs anemic) | 1.799 | 1.123-2.882 | 0.015 | 1.946 | 1.217-3.112 | 0.005 |
Tumor location (C vs U vs M vs L) | 0.945 | 0.739-1.208 | 0.650 | 0.935 | 0.729-1.199 | 0.595 |
Treatment modality (RT vs S + RT vs CRT vs S + CRT) | 0.856 | 0.681-1.076 | 0.183 | 0.916 | 0.741-1.133 | 0.420 |
TNM stage (I vs II vs III vs IV) | 1.732 | 1.240-2.418 | 0.001 | 1.783 | 1.263-2.518 | 0.001 |
T stage (T1 vs T2 vs T3 vs T4) | 1.319 | 0.988-1.761 | 0.060 | 1.441 | 1.071-1.939 | 0.016 |
Status of lymph node (negative vs positive) | 2.216 | 1.394-3.523 | 0.001 | 1.769 | 1.127-2.776 | 0.013 |